These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1974932)

  • 1. Suppression of ethanol-induced cardiac hypertrophy by beta-adrenoceptor blockade.
    King DC; Hirst M
    J Mol Cell Cardiol; 1990 May; 22(5):523-31. PubMed ID: 1974932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metoprolol suppresses the development of ethanol-induced cardiac hypertrophy in the rat.
    Adams MA; Hirst M
    Can J Physiol Pharmacol; 1990 May; 68(5):562-7. PubMed ID: 2140285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of adrenal medullectomy on the development of ethanol-induced cardiac hypertrophy.
    Adams MA; Hirst M
    Can J Physiol Pharmacol; 1986 May; 64(5):592-6. PubMed ID: 2942233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol-induced cardiac hypertrophy: correlation between development and the excretion of adrenal catecholamines.
    Adams MA; Hirst M
    Pharmacol Biochem Behav; 1986 Jan; 24(1):33-8. PubMed ID: 2935884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic application of propranolol on beta-adrenergic signal transduction in heart ventricles from myopathic BIO TO2 and control hamsters.
    Witte K; Schnecko A; Hauth D; Wirzius S; Lemmer B
    Br J Pharmacol; 1998 Nov; 125(5):1033-41. PubMed ID: 9846642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course and extent of alpha 1-adrenoceptor density changes in rat heart after beta-adrenoceptor blockade.
    Steinkraus V; Nose M; Scholz H; Thormählen K
    Br J Pharmacol; 1989 Feb; 96(2):441-9. PubMed ID: 2564293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of cardiac alpha 1-adrenoceptor involvement in ethanol-induced cardiac hypertrophy.
    Adams MA; Hirst M
    Can J Physiol Pharmacol; 1989 Mar; 67(3):240-5. PubMed ID: 2545320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade.
    Bedotto JB; Gay RG; Graham SD; Morkin E; Goldman S
    J Pharmacol Exp Ther; 1989 Feb; 248(2):632-6. PubMed ID: 2537405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac hypertrophy in rats after intravenous administration of CI-959, a novel antiinflammatory compound: morphologic features and pharmacokinetic and pharmacodynamic mechanisms.
    Low JE; Metz AL; Mertz TE; Henry SP; Knowlton P; Loewen G; Sommers CS; Robertson DG; Olszewski BJ; Schroeder RL
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):930-9. PubMed ID: 7564338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroxine-induced cardiac hypertrophy: time course of development and inhibition by propranolol.
    Klein I
    Endocrinology; 1988 Jul; 123(1):203-10. PubMed ID: 2968237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.
    Kaumann AJ; Molenaar P
    Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of aortic banding-induced cardiac hypertrophy by propranolol is independent of beta-adrenoceptor blockade.
    Marano G; Palazzesi S; Fadda A; Vergari A; Ferrari AU
    J Hypertens; 2002 Apr; 20(4):763-9. PubMed ID: 11910314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenergic activation of cardiac phospholipase D: role of alpha(1)-adrenoceptor subtypes.
    Mier K; Kemken D; Katus HA; Richardt G; Kurz T
    Cardiovasc Res; 2002 Apr; 54(1):133-9. PubMed ID: 12062369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
    Hanada K; Asari K; Saito M; Kawana J; Mita M; Ogata H
    Eur J Pharmacol; 2008 Jul; 589(1-3):194-200. PubMed ID: 18534575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol-induced cardiac hypertrophy: effects of peripheral sympathectomy.
    Hirst M; Adams MA
    Can J Physiol Pharmacol; 1987 Dec; 65(12):2363-7. PubMed ID: 2966664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic ethanol treatment of rats and the myocardial beta-adrenoceptors.
    Pohorecky LA; Hamm M; Chaudhury H; Ponticiello R; Knapp DJ
    Alcohol; 1992; 9(4):305-9. PubMed ID: 1353351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of beta 1- and beta 1 + beta 2-antagonists on training-induced myocardial hypertrophy and enzyme adaptation.
    Ji LL; Stratman FW; Lardy HA
    Biochem Pharmacol; 1987 Oct; 36(20):3411-7. PubMed ID: 2890350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of changes in sarcoplasmic reticular gene expression in cardiac hypertrophy by propranolol and verapamil.
    Takeo S; Elmoselhi AB; Goel R; Sentex E; Wang J; Dhalla NS
    Mol Cell Biochem; 2000 Oct; 213(1-2):111-8. PubMed ID: 11129949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol promotes Egr1 gene expression in cardiomyocytes via beta-adrenoceptors.
    Patrizio M; Musumeci M; Stati T; Fecchi K; Mattei E; Catalano L; Marano G
    Eur J Pharmacol; 2008 Jun; 587(1-3):85-9. PubMed ID: 18485346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptations to iron deficiency: cardiac functional responsiveness to norepinephrine, arterial remodeling, and the effect of beta-blockade on cardiac hypertrophy.
    Turner LR; Premo DA; Gibbs BJ; Hearthway ML; Motsko M; Sappington A; Walker L; Mullendore ME; Chew HG
    BMC Physiol; 2002; 2():1. PubMed ID: 11818034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.